Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats


      Momordica charantia (karela) is commonly used as an antidiabetic and antihyperglycemic agent in Asian, Oriental and Latin American countries. This study was undertaken to investigate the effects of long term feeding (10 weeks) of M. charantia fruit extract on blood plasma and tissue lipid profiles in normal and streptozotocin (STZ) -induced Type 1 diabetic rats. The results show that there was a significant (P<0.05) increase in plasma non-esterified cholesterol, triglycerides and phospholipids in STZ-induced diabetic rats, accompanied by a decrease in high density lipoprotein (HDL) -cholesterol. A moderate increase in plasma (LPO) product, malonedialdehyde (MDA), and about two-fold increase in kidney LPO was also observed in STZ-induced diabetic rats. The treatment of diabetic rats with M. charantia fruit extract over a 10-week period returned these levels close to normal. In addition, karela juice also exhibited an inhibitory effect on membrane LPO under in vitro conditions. These results suggest that M. charantia fruit extract exhibits hypolipidemic as well as hypoglycemic effects in the STZ-induced diabetic rat.



      HDL, high density lipoprotein (), LDL, low density lipoprotein (), LPO, lipid peroxidation (), MDA, malonedialdehyde (), STZ, streptozotocin (), TBARS, thiobarbituric acid reactive substances ()
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Betteridge J.
        Lipid disorders in diabetes mellitus.
        in: Pickup J.C. Williams G. Text Book of Diabetes. second ed. Blackwell Science, London1997: 55.1-55.31
        • Jilka C.
        • Strifler B.
        • Fortner G.W.
        • Hays E.F.
        • Takemoto D.J.
        In vivo antitumor activity of the bitter melon (Momordica charantia).
        Cancer Res. 1983; 43: 5151-5155
        • Guevara A.P.
        • Lim-Sylianco C.
        • Dayrit F.
        • Finch P.
        Antimutagens from Momordica charantia.
        Mutat. Res. 1990; 230: 121-126
        • Ng T.B.
        • Chan W.Y.
        • Yeung H.W.
        Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceal plants.
        Gen. Pharmacol. 1992; 23: 579-590
        • Karunanayake E.H.
        • Tennekoon K.H.
        Search of novel hypoglycaemic agents from medicinal plants.
        in: Sharma A.K. Diabetes Mellitus and Its Complications, An Update. Macmillan India Ltd, New Delhi, India1993: 192-205
        • Platel K.
        • Srinivasan K.
        Plants foods in the management of diabetes mellitus: vegetables as potential hypoglycemic agents.
        Nahrung. 1997; 41: 68-74
        • Welihinda J.
        • Karunanayake E.H.
        • Sheriff M.H.R.
        • Jayasinghe K.S.A.
        Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.
        J. Ethnopharmacol. 1986; 17: 277-282
        • Welihinda J.
        • Arvidson G.
        • Gylfe E.
        • Hellman B.
        • Karlsson E.
        The insulin releasing activity of the tropical plant Momordica charantia.
        Acta Biol. Med. Germ. 1982; 41: 1229-1240
        • Leatherdale B.A.
        • Panesar R.K.
        • Singh G.
        • Atkins T.W.
        • Bailey C.J.
        • Bignell A.H.
        Improvement in glucose tolerance due to Momordica charantia (Karela).
        Br. Med. J. 1981; 282: 1823-1824
        • Ali L.
        • Khan A.K.
        • Mamun M.I.
        • Mosihuzzaman M.
        • Nahar N.
        • Nur-E-Alam M.
        • Rokeya B.
        Studies on hypoglycemic in effects of fruit pulp seed and whole plant of Momordia charantia on normal and diabetic model rats.
        Planta Med. 1993; 59: 408-412
        • Ahmed I.
        • Adeghate E.
        • Sharma A.K.
        • Pallot D.J.
        • Singh J.
        Effects of Momordica charantia fruit juice on islet morphology in the pancreas of streptozotocin-diabetic rats.
        Diabetes Res. Clin. Pract. 1998; 40: 145-151
        • Choi J.S.
        • Yokozawa T.
        • Oura H.
        Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin.
        Planta Med. 1991; 57: 208-211
        • Platel K.
        • Shurpalekar K.S.
        • Srinivasan K.
        Effect of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats.
        Nahrung. 1993; 37: 156-160
        • Sharma S.R.
        • Dwivedi S.K.
        • Swarup D.
        Hypoglycaemic, antihyperglycaemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats.
        J. Ethnopharmacol. 1997; 58: 39-44
        • Prince P.S.M.
        • Menon V.P.
        • Gunasekaran G.
        Hypolipidaemic action of Tinospora cordifolia roots in alloxan diabetic rats.
        J. Ethnopharmacol. 1999; 64: 53-57
        • Rao B.K.
        • Kesavulu M.M.
        • Giri R.
        • Rao C.A.
        Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. Fruit powder in alloxan-diabetic rats.
        J. Ethnopharmacol. 1999; 67: 103-109
        • Sharma A.K.
        • Ahmed I.
        • Tadayyon M.
        • Ponery A.S.
        • Aloamaka P.
        • Absood G.
        • Pallot D.J.
        The beneficial effects of Momordica charantia fruit juice on streptozotocin induced diabetes and hypertension in rats.
        Int. J. Diabetes. 1996; 4: 29-38
        • Bradford M.M.
        A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
        Anal. Biochem. 1976; 72: 248-254
        • Bartlett G.R.
        Phosphorus assay in column chromatography.
        J. Biol. Chem. 1959; 234: 466-468
        • Bhagwat S.V.
        • Vijayasarathy C.
        • Raza H.
        • Mullick J.
        • Avadhani N.G.
        Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1,3-(3-pyridyl)-1butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain.
        Biochem. Pharmacol. 1998; 56: 831-839
        • Brown G.B.
        • Xue-Qiao Z.
        • Sacco D.E.
        • Alberts J.J.
        Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
        Circulation. 1993; 87: 1781-1791
        • Ng T.B.
        • Li W.W.
        • Yeung H.W.
        Effect of ginsenosides, lectins and Momordica charantia insulin-like peptide on corticosterone production by isolated rat adrenal cells.
        J. Ethnopharmacol. 1987; 21: 21-29
        • Laakso M.
        Epidemiology of diabetic dyslipidemia.
        Diabetic Rev. 1995; 3: 408-422
        • Feillet-Coudray C.
        • Rock E.
        • Coudray C.
        • Grzelkowska K.
        • Azais-Braesco V.
        • Dardevet D.
        • Mazur A.
        Lipid peroxidation and antioxidant status in experimental diabetes.
        Clin. Chim. Acta. 1999; 284: 31-43
        • Raza H.
        • Ahmed I.
        • John A.
        • Sharma A.K.
        Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract.
        J. Biochem. Mol. Toxicol. 2000; 14: 131-139
        • Johnson M.B.
        • Heineke E.W.
        • Rhinehart B.L.
        • Sheetz M.J.
        • Bamhart R.L.
        • Robinson K.M.
        MDL 29311: antioxidant with marked lipid- and glucose lowering activity in diabetic rats and mice.
        Diabetes. 1993; 42: 1179-1186
        • Yoshioka T.
        • Fujita T.
        • Kanai T.
        • Aizawa Y.
        • Kurumada T.
        • Hasegawa K.
        • Horikoshi H.
        Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation.
        J. Med. Chem. 1989; 32: 421-428